Back
Spyre Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
68
SYRE
Spyre Therapeutics, Inc.
Last Price:
$43.00
Seasonality Move:
-6.34%
7 Day Trial
ALL ACCESS PASS
$
7
Spyre Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Spyre Therapeutics, Inc. has on average historically risen by 14.8% based on the past 9 years of stock performance.
-
Spyre Therapeutics, Inc. has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
-
Is Spyre Therapeutics, Inc. Stock Undervalued?The current Spyre Therapeutics, Inc. [SYRE] share price is $43.01. The Score for SYRE is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
-
SYRE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Spyre Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Spyre Therapeutics, Inc. has on average historically risen by 14.8% based on the past 9 years of stock performance.
Spyre Therapeutics, Inc. Stock Rating
Buy
68
Spyre Therapeutics, Inc. (SYRE)
is a Buy
Is Spyre Therapeutics, Inc. overpriced?
-
Spyre Therapeutics, Inc. has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
Spyre Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
spyre.com
52-Week Data
52-Week High:
45.76
52-Week Low:
10.91
Prediction Charts
Market Cap:
3.4B
Price in USD:
43.01
Volume:
695.2K
Beta:
2.45
Technical Analysis
SMA50:
34.37
SMA100:
29.79
SMA200:
22.96
52-Wk Change:
134.13%
Stock Predictions
-
Is Spyre Therapeutics, Inc. stock public?Yes, Spyre Therapeutics, Inc. is a publicly traded company.
-
What is the Spyre Therapeutics, Inc. stock quote today?The Spyre Therapeutics, Inc. stock price is 43.01 USD today.
-
How to buy Spyre Therapeutics, Inc. stock online?You can buy Spyre Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-9 | 35.12 | 33.96 | 35.58 | 33.78 |
| Feb-10 | 34.28 | 33.56 | 34.93 | 33.19 |
| Feb-11 | 33.59 | 33.92 | 34.13 | 32.35 |
| Feb-12 | 33.98 | 34.84 | 34.92 | 33.59 |
| Feb-13 | 35.02 | 36.63 | 37.98 | 35.02 |
| Feb-17 | 36.39 | 35.95 | 37.22 | 34.96 |
| Feb-18 | 36.05 | 36.60 | 37.66 | 35.93 |
| Feb-19 | 36.66 | 37.81 | 38.16 | 35.93 |
| Feb-20 | 37.82 | 43.21 | 43.56 | 37.81 |
| Feb-23 | 43.01 | 44.18 | 45.76 | 42.26 |
| Feb-24 | 44.17 | 43.45 | 44.81 | 43.05 |
| Feb-25 | 44.18 | 43.88 | 44.88 | 43.43 |
| Feb-26 | 43.79 | 43.15 | 44.26 | 42.03 |
| Feb-27 | 42.42 | 43.01 | 43.80 | 42.27 |
Spyre Therapeutics, Inc. Earnings
Spyre Therapeutics, Inc. Earnings Report: Per Share Spyre Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Spyre Therapeutics, Inc. Forecast Revenue Growth
Spyre Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Spyre Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.51 per share, a decrease this year of $0.75 per share, and a decrease next year of $0.15 per share.
* Spyre Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.